Endothelial Therapy of Atherosclerosis and its Risk Factors
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
111-121
Author(s):
Tobias Traupe, Jana Ortmann, Klaus Munter and Matthias Barton
Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
123-133
Author(s):
C. P. Tiefenbacher and J. Kreuzer
Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
135-156
Author(s):
Fan Jiang and Gregory J. Dusting
Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
157-169
Author(s):
Patrizia Ferroni, Stefania Basili and Giovanni Davi
Clinical Value of Prostacyclin and its Analogs in the Management of Pulmonary Arterial Hypertension
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
171-181
Author(s):
Michael Dandel and Roland Hetzer
Vulnerable Atherosclerotic Plaque: Clinical Implications
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
183-204
Author(s):
Jinho Shin, Jay E. Edelberg and Mun K. Hong
Treatment of Chronic Peripheral Arterial Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
205-216
Author(s):
P. L. Antignani
A Novel Therapeutic Strategy Against Vascular Disorders with Chymase Inhibitor
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
217-224
Author(s):
Shinji Takai and Mizuo Miyazaki
Diabetes, the Renin-Angiotensin System and Heart Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
225-238
Author(s):
Hoong Sern Lim and Gregory Y.H. Lip
From CHD Susceptibility Genes to New Therapeutics
Journal:
Current Pharmacogenomics
Volume:
1
Page:
111-125
Author(s):
Gerd Schmitz, Thomas Langmann, Susanne Heimerl and Christoph Schumacher